H.R.7845: NIH Clinical Trial Diversity Act of 2022

About This Bill

Bill Sponsor

Bill Version

Bill Summary

NIH Clinical Trial Diversity Act of 2022 This bill sets out requirements to increase the diversity of clinical trial participants. The bill also requires other activities to foster participation in clinical trials. As a condition of funding from the National Institutes of Health (NIH) for a clinical trial investigating a drug or device, a sponsor's application must include certain information related to diversity in its trial, such as goals...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with H.R.7845.

Bill Actions

Date Description
May 20, 2022
Referred to the Subcommittee on Health.
May 19, 2022
Referred to the House Committee on Energy and Commerce.
May 19, 2022

Introduced in the House by Robin Kelly (D-Ill.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page